Clinical Trial Results:
            A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the
Safety and Antiretroviral Activity of MK-0518 in Combination With an Optimized
Background Therapy (OBT), Versus Optimized Background Therapy Alone, in HIVInfected Patients With Documented Resistance to at Least 1 Drug in Each of the 3
Classes of Licensed Oral Antiretroviral Therapies
    
|     Summary | |
|     EudraCT number | 2005-005127-34 | 
|     Trial protocol | DE DK ES PT BE IT | 
|     Global completion date | 
                                    18 May 2011
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    30 Mar 2016
                             | 
|     First version publication date | 
                                    30 Mar 2016
                             | 
|     Other versions | |
|     Summary report(s) | clinicaltrials.gov results | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
